NO993096D0 - Orale cyklosporinformuleringer - Google Patents

Orale cyklosporinformuleringer

Info

Publication number: NO993096D0
Authority: NO; Norway
Prior art keywords: oral cyclosporine; cyclosporine formulations; formulations; oral; cyclosporine
Prior art date: 1997-10-23

Application number

NO993096A

Other languages

English (en)

Other versions

NO993096L (no

Inventor

Moo J Chu

Ralph E Levy

Philippe J Pouletty

Original Assignee

Sangstat Medical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-23

Filing date

1999-06-22

Publication date

1999-06-22

1999-06-22 Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp

1999-06-22 Publication of NO993096D0 publication Critical patent/NO993096D0/no

1999-08-17 Publication of NO993096L publication Critical patent/NO993096L/no

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
108010036949 Cyclosporine Proteins 0.000 title 1
229960001265 ciclosporin Drugs 0.000 title 1
229930182912 cyclosporin Natural products 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/50—Treatment of water, waste water, or sewage by addition or application of a germicide or by oligodynamic treatment
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/42—Nature of the water, waste water, sewage or sludge to be treated from bathing facilities, e.g. swimming pools
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/008—Mobile apparatus and plants, e.g. mounted on a vehicle
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2301/00—General aspects of water treatment
- C02F2301/04—Flow arrangements
- C02F2301/046—Recirculation with an external loop

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dispersion Chemistry (AREA)
Hydrology & Water Resources (AREA)
Environmental & Geological Engineering (AREA)
Water Supply & Treatment (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO993096A 1997-10-23 1999-06-22 Orale cyklosporinformuleringer NO993096L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/956,841 US5962019A (en)	1995-08-25	1997-10-23	Oral cyclosporin formulations
PCT/US1998/022330 WO1999020296A1 (en)	1997-10-23	1998-10-21	Oral cyclosporin formulations

Publications (2)

Publication Number	Publication Date
NO993096D0 true NO993096D0 (no)	1999-06-22
NO993096L NO993096L (no)	1999-08-17

Family

ID=25498759

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO993096A NO993096L (no)	1997-10-23	1999-06-22	Orale cyklosporinformuleringer

Country Status (20)

Country	Link
US (1)	US5962019A (no)
EP (1)	EP0956035A1 (no)
JP (1)	JP2000516267A (no)
KR (1)	KR20000069688A (no)
CN (1)	CN1246057A (no)
AR (1)	AR013710A1 (no)
AU (1)	AU9810698A (no)
BR (1)	BR9806271A (no)
CA (1)	CA2275773A1 (no)
HU (1)	HUP0004733A3 (no)
IL (1)	IL130631A0 (no)
NO (1)	NO993096L (no)
NZ (1)	NZ336253A (no)
PL (1)	PL334100A1 (no)
RU (1)	RU2174405C2 (no)
SK (1)	SK97199A3 (no)
TR (1)	TR199901448T1 (no)
TW (1)	TW592707B (no)
WO (1)	WO1999020296A1 (no)
ZA (1)	ZA989684B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858401A (en) *	1996-01-22	1999-01-12	Sidmak Laboratories, Inc.	Pharmaceutical composition for cyclosporines
KR20000069900A (ko) *	1997-01-30	2000-11-25	한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터	오일을 함유하지 않은 사이클로스포린 ａ 함유 제약 조성물
NZ512599A (en)	1998-12-30	2003-10-31	Dexcel Ltd	Formulation for cyclosporin administration featuring a hydrophilic solvent and a surfactant with a HLB of less than 5
US6057289A (en) *	1999-04-30	2000-05-02	Pharmasolutions, Inc.	Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
EP1214059B1 (en) *	1999-09-21	2005-05-25	Skyepharma Canada Inc.	Surface modified particulate compositions of biologically active substances
US6828302B1 (en)	1999-12-08	2004-12-07	Xcyte Therapies, Inc.	Therapeutic uses of depsipeptides and congeners thereof
ATE353663T1 (de)	1999-12-08	2007-03-15	Cyclacel Pharmaceuticals Inc	Verwendung von depsipeptide und deren analoge als immunosuppressiva zur behandlung von infektionskrankheiten, autoimmunerkrankungen, allergien und hyperproliferativer hautkrankheiten
US7732404B2 (en)	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
AR033711A1 (es) *	2001-05-09	2004-01-07	Novartis Ag	Composiciones farmaceuticas
US6960563B2 (en) *	2001-08-31	2005-11-01	Morton Grove Pharmaceuticals, Inc.	Spontaneous emulsions containing cyclosporine
US20030054042A1 (en) *	2001-09-14	2003-03-20	Elaine Liversidge	Stabilization of chemical compounds using nanoparticulate formulations
RU2337106C2 (ru) *	2001-10-19	2008-10-27	Изотехника Инк.	Смесь аналогов циклоспорина и ее применение в качестве иммуномодулирующего агента
MXPA04003623A (es) *	2001-10-19	2004-12-02	Isotechnika Inc	Nuevas formulaciones analogas de ciclosporina.
US20050059583A1 (en)	2003-09-15	2005-03-17	Allergan, Inc.	Methods of providing therapeutic effects using cyclosporin components
US7282194B2 (en) *	2004-10-05	2007-10-16	Gp Medical, Inc.	Nanoparticles for protein drug delivery
JP2008535921A (ja)	2005-04-12	2008-09-04	エラン・ファルマ・インターナショナル・リミテッド	シクロスポリンを含むナノ粒子および放出調節された組成物
US7202209B2 (en)	2005-07-13	2007-04-10	Allergan, Inc.	Cyclosporin compositions
US7297679B2 (en)	2005-07-13	2007-11-20	Allergan, Inc.	Cyclosporin compositions
US20070015693A1 (en) *	2005-07-13	2007-01-18	Allergan, Inc.	Cyclosporin compositions
US7276476B2 (en) *	2005-07-13	2007-10-02	Allergan, Inc.	Cyclosporin compositions
US7288520B2 (en)	2005-07-13	2007-10-30	Allergan, Inc.	Cyclosporin compositions
US20070015691A1 (en) *	2005-07-13	2007-01-18	Allergan, Inc.	Cyclosporin compositions
US7501393B2 (en) *	2005-07-27	2009-03-10	Allergan, Inc.	Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) *	2005-10-14	2010-06-29	Gregg Feinerman	Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en)	2005-10-14	2017-12-12	Allergan, Inc.	Prevention and treatment of ocular side effects with a cyclosporin
CN101437501B (zh) *	2006-03-02	2012-09-05	阿莱克申药物公司	通过抑制补体活性延长同种异体移植物的存活
CN101032620B (zh) *	2007-03-08	2010-05-19	上海凯昭医药科技有限公司	一种环孢素自乳化制剂及其制备方法
CN101678034A (zh) *	2007-03-30	2010-03-24	佛维雅制药股份有限公司	治疗新血管眼病的方法
EA019867B1 (ru) *	2007-10-08	2014-06-30	Фовея Фармасьютикалс	Водные офтальмологические препараты
US20180177879A1 (en) *	2015-06-05	2018-06-28	Maruho Co., Ltd	External preparation for transdermal administration

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US506219A (en) *		1893-10-10		Steam-cooker
US4117118A (en) *	1976-04-09	1978-09-26	Sandoz Ltd.	Organic compounds
DE2819094A1 (de) *	1977-05-10	1978-11-23	Sandoz Ag	Cyclosporin-derivate, ihre verwendung und herstellung
FI65914C (fi) *	1978-03-07	1984-08-10	Sandoz Ag	Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
GB8305693D0 (en) *	1983-03-02	1983-04-07	Scherer Ltd R P	Pharmaceutical compositions
GB8903804D0 (en) *	1989-02-20	1989-04-05	Sandoz Ltd	Improvements in or relating to organic compounds
US5118493A (en) *	1986-05-02	1992-06-02	Brigham And Women's Hospital	Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine
NL194638C (nl) *	1986-12-19	2002-10-04	Novartis Ag	Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
US4792449A (en) *	1987-01-28	1988-12-20	Baxter Travenol Laboratories, Inc.	Method for drug administration
US5154930A (en) *	1987-03-05	1992-10-13	The Liposome Company, Inc.	Pharmacological agent-lipid solution preparation
KR880012221A (ko) *	1987-04-13	1988-11-26	사노 가즈오	에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
JP2577049B2 (ja) *	1987-06-04	1997-01-29	三共株式会社	シクロスポリン製剤
HU205010B (en) *	1987-09-15	1992-03-30	Sandoz Ag	Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
GB8729153D0 (en) *	1987-12-14	1988-01-27	Efamol Ltd	Fatty acid compositions
HU203564B (en) *	1987-12-21	1991-08-28	Sandoz Ag	Process for producing new orthorombos cyclosporin without solvatation
ES2033086T3 (es) *	1988-01-29	1993-03-01	Sankyo Company Limited	Un procedimiento para la preparacion de una composicion farmaceutica.
HU201567B (en) *	1988-07-21	1990-11-28	Gyogyszerkutato Intezet	Process for production of intravenous medical compositions containing cyclosphorin
US5350741A (en) *	1988-07-30	1994-09-27	Kanji Takada	Enteric formulations of physiologically active peptides and proteins
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
BE1003578A4 (fr) *	1988-10-26	1992-04-28	Sandoz Sa	Nouvelles compositions ophtalmiques a base d'une cyclosporine.
BE1003009A5 (fr) *	1989-02-09	1991-10-22	Sandoz Sa	Nouvelles compositions pharmaceutiques a base de cyclosporines.
US4996193A (en) *	1989-03-03	1991-02-26	The Regents Of The University Of California	Combined topical and systemic method of administration of cyclosporine
US5364632A (en) *	1989-04-05	1994-11-15	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Medicinal emulsions
AU654483B2 (en) *	1990-04-18	1994-11-10	University Of Utah Research Foundation	Crosslinked hydrogels containing azobonds
JPH04253907A (ja) *	1990-05-23	1992-09-09	Green Cross Corp:The	静脈注射用免疫抑制剤
US5393791A (en) *	1990-07-19	1995-02-28	Helena Chemical Company	Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
HU208491B (en) *	1990-11-27	1993-11-29	Gyogyszerkutato Intezet	Process for producing oral pharmaceutical composition containing cyclosporin
US5122383A (en) *	1991-05-17	1992-06-16	Theratech, Inc.	Sorbitan esters as skin permeation enhancers
MX9201782A (es) *	1991-04-19	1992-10-01	Sandoz Ag	Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
IL102236A0 (en) *	1991-06-27	1993-01-14	Ltt Inst Co Ltd	Topical preparations containing cyclosporin
JPH0558906A (ja) *	1991-09-06	1993-03-09	Sankyo Co Ltd	シクロスポリン点眼製剤
GB9208712D0 (en) *	1992-04-22	1992-06-10	Sandoz Ltd	Pharmaceutical compositions containing cyclosporin derivates
EP0642332B1 (en) *	1992-05-13	1997-01-15	Sandoz Ltd.	Ophthalmic compositions containing a cyclosporin
IT1260505B (it) *	1992-06-01	1996-04-09	Poli Ind Chimica Spa	Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
ES2168271T3 (es) *	1992-09-25	2002-06-16	Novartis Ag	Composiciones farmaceuticas que contienen ciclosporinas.
PT697881E (pt) *	1993-04-20	2002-10-31	Novartis Ag	Novas composicoes farmaceuticas contendo ciclosporina para administracao oral
CN1077800C (zh) *	1993-07-01	2002-01-16	韩美药品工业株式会社	环孢菌素软胶囊组合物
DE4329503A1 (de) *	1993-09-01	1995-03-02	Galenik Labor Freiburg Gmbh	Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
DE4340781C3 (de) *	1993-11-30	2000-01-27	Novartis Ag	Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) *	1994-02-25	1998-08-17	김충환	사이클로스포린-함유 분말 조성물
EP0789580B1 (de) *	1994-11-03	2002-06-05	Novartis AG	Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
HU215966B (hu) *	1994-11-21	1999-07-28	BIOGAL Gyógyszergyár Rt.	Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) *	1994-12-28	1999-01-15	한스 루돌프 하우스, 니콜 케르커	사이클로스포린-함유 연질캅셀제 조성물
US5827822A (en) *	1996-03-25	1998-10-27	Sangstat Medical Corporation	Cyclosporin a formulations as nanoparticles
DE69632125T2 (de) *	1995-08-25	2004-09-16	Sangstat Medical Corp., Menlo Park	Orale cyclosporinformulierungen
US5766629A (en) *	1995-08-25	1998-06-16	Sangstat Medical Corporation	Oral cyclosporin formulations
NZ280689A (en) *	1995-12-15	1997-08-22	Bernard Charles Sherma Sherman	Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
SI0969856T1 (en) *	1997-03-12	2005-06-30	Abbott Laboratories	Hydrophilic binary systems for the administration of cyclosporine

1997
- 1997-10-23 US US08/956,841 patent/US5962019A/en not_active Expired - Fee Related
1998
- 1998-10-21 RU RU99113343/14A patent/RU2174405C2/ru active
- 1998-10-21 CN CN98801568A patent/CN1246057A/zh active Pending
- 1998-10-21 EP EP98952393A patent/EP0956035A1/en not_active Withdrawn
- 1998-10-21 JP JP11524568A patent/JP2000516267A/ja active Pending
- 1998-10-21 KR KR1019997005738A patent/KR20000069688A/ko not_active Abandoned
- 1998-10-21 SK SK97199A patent/SK97199A3/sk unknown
- 1998-10-21 IL IL13063198A patent/IL130631A0/xx unknown
- 1998-10-21 BR BR9806271-9A patent/BR9806271A/pt not_active IP Right Cessation
- 1998-10-21 HU HU0004733A patent/HUP0004733A3/hu unknown
- 1998-10-21 TW TW087117445A patent/TW592707B/zh active
- 1998-10-21 NZ NZ336253A patent/NZ336253A/en unknown
- 1998-10-21 AU AU98106/98A patent/AU9810698A/en not_active Abandoned
- 1998-10-21 TR TR1999/01448T patent/TR199901448T1/xx unknown
- 1998-10-21 PL PL98334100A patent/PL334100A1/xx unknown
- 1998-10-21 WO PCT/US1998/022330 patent/WO1999020296A1/en not_active Ceased
- 1998-10-21 CA CA002275773A patent/CA2275773A1/en not_active Abandoned
- 1998-10-22 AR ARP980105274A patent/AR013710A1/es not_active Application Discontinuation
- 1998-10-23 ZA ZA989684A patent/ZA989684B/xx unknown
1999
- 1999-06-22 NO NO993096A patent/NO993096L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SK97199A3 (en)	2004-10-05
JP2000516267A (ja)	2000-12-05
HUP0004733A2 (hu)	2001-05-28
NO993096L (no)	1999-08-17
CN1246057A (zh)	2000-03-01
PL334100A1 (en)	2000-01-31
TR199901448T1 (xx)	1999-12-21
HUP0004733A3 (en)	2001-12-28
KR20000069688A (ko)	2000-11-25
AU9810698A (en)	1999-05-10
BR9806271A (pt)	2000-04-04
RU2174405C2 (ru)	2001-10-10
TW592707B (en)	2004-06-21
WO1999020296A1 (en)	1999-04-29
AR013710A1 (es)	2001-01-10
CA2275773A1 (en)	1999-04-29
IL130631A0 (en)	2000-06-01
NZ336253A (en)	2001-06-29
ZA989684B (en)	1999-04-25
EP0956035A1 (en)	1999-11-17
US5962019A (en)	1999-10-05

Publication	Publication Date	Title
NO993096D0 (no)	1999-06-22	Orale cyklosporinformuleringer
MA24473A1 (fr)	1998-10-01	Formulations
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
NO20004240L (no)	2000-10-18	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
ID23299A (id)	2000-04-05	Formulasi-formulasi farmasi
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
PT973527E (pt)	2004-01-30	Formulacoes de libertacao prolongada de claritromicina
ID22939A (id)	1999-12-16	Formulasi-formulasi farmasi yang mengandung vorikonozal
EE9800123A (et)	1998-10-15	Stabiilsed lüofiliseeritud ravimvormid
ID20233A (id)	1998-10-29	Komposisi oral
NO20001631L (no)	2000-05-30	2-metyl-tieno-benzodiazepin formulering
DE69518331D1 (de)	2000-09-14	Orale zubereitungen
ID19097A (id)	1998-06-11	Komposisi-komposisi oral
ATE227074T1 (de)	2002-11-15	Mikrokapsel-formulierungen
DE69822172D1 (de)	2004-04-08	Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
CY2006006I1 (el)	2009-11-04	Πρωτεϊνικα σκευασματα
IS6398A (is)	2002-05-27	Lyfjablöndur
ATE263550T1 (de)	2004-04-15	Orale cyclosporinformulierungen
ATE357237T1 (de)	2007-04-15	Formulierungen enthaltend cefuroxim-axetil
ATE232683T1 (de)	2003-03-15	Mikrokapsel-formulierungen
PT868911E (pt)	2002-12-31	Formulacoes de rapamicina para administracao oral
ID20466A (id)	1998-12-24	Komposisi oral

Legal Events

Date	Code	Title	Description
2003-06-16	FC2A	Withdrawal, rejection or dismissal of laid open patent application